On Monday, Geron Corp (NASDAQ: GERN) opened lower -1.41% from the last session, before settling in for the closing price of $1.42. Price fluctuations for GERN have ranged from $1.17 to $5.34 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 6535.01% annually for the last half of the decade. Company’s average yearly earnings per share was noted 56.79% at the time writing. With a float of $597.84 million, this company’s outstanding shares have now reached $606.39 million.
In an organization with 229 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 97.97%, operating margin of -225.64%, and the pretax margin is -226.73%.
Geron Corp (GERN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Geron Corp is 6.13%, while institutional ownership is 76.62%. The most recent insider transaction that took place on Feb 27 ’25, was worth 24,150. In this transaction EVP, Chief Legal Officer of this company bought 15,000 shares at a rate of $1.61, taking the stock ownership to the 26,682 shares. Before that another transaction happened on Feb 27 ’25, when Company’s Chairman, President and CEO bought 12,500 for $1.76, making the entire transaction worth $22,062. This insider now owns 12,500 shares in total.
Geron Corp (GERN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.03 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 56.79% per share during the next fiscal year.
Geron Corp (NASDAQ: GERN) Trading Performance Indicators
Check out the current performance indicators for Geron Corp (GERN). In the past quarter, the stock posted a quick ratio of 5.12. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.58.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.27, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.00 in one year’s time.
Technical Analysis of Geron Corp (GERN)
Let’s dig in a bit further. During the last 5-days, its volume was 8.51 million. That was inferior than the volume of 14.39 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 80.69%. Additionally, its Average True Range was 0.12.
During the past 100 days, Geron Corp’s (GERN) raw stochastic average was set at 7.81%, which indicates a significant decrease from 75.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 80.79% in the past 14 days, which was lower than the 84.33% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6904, while its 200-day Moving Average is $3.4390. However, in the short run, Geron Corp’s stock first resistance to watch stands at $1.4600. Second resistance stands at $1.5200. The third major resistance level sits at $1.5650. If the price goes on to break the first support level at $1.3550, it is likely to go to the next support level at $1.3100. Assuming the price breaks the second support level, the third support level stands at $1.2500.
Geron Corp (NASDAQ: GERN) Key Stats
There are currently 636,913K shares outstanding in the company with a market cap of 891.68 million. Presently, the company’s annual sales total 76,990 K according to its annual income of -174,570 K. Last quarter, the company’s sales amounted to 47,540 K and its income totaled -25,350 K.
